MedTech sector outlook for 2025: RBC

RBC Capital Markets expresses optimism for the MedTech sector in 2025, highlighting growth opportunities driven by innovation, favorable demographics, and supportive policies.

Earnings call: Globus Medical reports robust Q3 growth, eyes 2025 prospects

Globus Medical stock gains 7% on strong Q3 results, raised guidance

Globus Medical's shares rose 7.4% after strong Q3 earnings of $0.83 EPS and $625.7 million revenue, surpassing expectations and raising full-year guidance to $2.90-$3.00.